Syndax(SNDX) - 2023 Q1 - Earnings Call Transcript

Peter Lawson - Barclays Justin Zelin - BTIG Sharon Klahre Michael Metzger We also welcome Kevin McManus to the company, as our new Chief People Officer. We look forward to benefiting from his extensive experience and vision in building our organization and culture. We have several additional trials ongoing designed to expand the potential of revumenib beyond used as a monotherapy agent in patients with relapsed/refractory acute leukemias including combinations with standardof-care regimens to treat these fo ...